Purpose: Axicabtagene ciloleucel (axi-cel) was recently approved for treatment of relapsed
or refractory (R/R) large B-cell lymphoma (LBCL) following two or more prior therapies. As …

Current treatment approaches toward spinal cord injuries (SCI) have mainly focused on
overcoming the inhibitory microenvironment that surrounds lesion sites. Unfortunately, the mere …

Objectives To develop a version of the Montreal Cognitive Assessment (MoCA) to be
administered to the severely hearing impaired (HI‐MoCA), and to assess its performance in two …

The capacity of adult mammals to regenerate sensory hair cells is not well defined. To
explore early steps in this process, we examined reactivation of a transiently expressed …

One key to the success of Mycobacterium tuberculosis as a pathogen is its ability to reside
in the hostile environment of the human macrophage. Bacteria adapt to stress through a …

Listening to speech in noise is effortful for individuals with hearing loss, even if they have
received a hearing prosthesis such as a hearing aid or cochlear implant (CI). At present, little is …

Background Hearing loss is one of the leading causes of disability worldwide. Patients with
hearing loss experience impaired quality of life, as well as emotional and financial …

A system has been developed which utilizes variational geometry in the design and modification
of mechanical parts. Three-dimensional constraints between characteristic points are …

Context New evidence has emerged regarding the use of corticosteroids and antiviral agents
in Bell palsy. Objective To estimate the association of corticosteroids and antiviral agents …

Primary squamous cell carcinomas (SCCs) of the middle ear and temporal bone are rare
and usually keratinizing by morphology. Nonkeratinizing, basaloid SCCs arising in this area …